Background The interactions between antiretroviral therapy (ART) and high-risk human
papillomavirus (HPV) and cervical lesions in women living with HIV are poorly understood …

The identification of high-risk human papillomavirus (HPV) types as a necessary cause of
cervical cancer offers the prospect of effective primary prevention and the possibility of …

Objective: HIV-positive women have higher human papillomavirus (HPV) prevalence and
cervical cancer incidence than HIV-negative women, partly because of HIV's modifying effect …

Human papillomavirus (HPV) has been identified as a necessary factor in the development
of pre-invasive and invasive cancers of the lower genital tract, of which cervical cancer is the …

Clinical and subclinical human papillomavirus (HPV) infections are the most common
sexually transmitted infections in the world, and most sexually-active individuals are likely to …

Background: Little is known in human immunodeficiency virus (HIV)–positive women about
how the combination of plasma HIV RNA level and CD4+ T-cell count is associated with the …

This ninetieth volume of the IARC Monographs on the Evaluation of Carcinogenic Risks to
Humansconsiders human papillomaviruses (HPVs) which were evaluated by a previous …

Detection of persistent cervical carcinogenic human papillomavirus (HPV) DNA is used as a
marker for cervical cancer risk in clinical trials. The authors performed a systematic review …

Background: HIV-positive women have a high prevalence of human papillomavirus (HPV)
infection and are infected with a broader range of HPV types than HIV-negative women. It is …

Persistent high‐risk human papillomavirus (HR‐HPV) infection is the strongest risk factor for
high‐grade cervical precancer. We performed a systematic review and meta‐analysis of …